Incidence, prevalence, and national burden of interstitial lung diseases in India: estimates from two studies of 3089 subjects
One NMA comparing GLP-1 agents (dulaglutide, exenatide, efpeglenatide, liraglutide, lixisenatide, semaglutide, and taspoglutide) in terms of change in weight and AEs in adults with obesity or overweight was found 31 and the results for semaglutide versus liraglutide 3.0 mg were consistent with the results for the sponsor-submitted NMA
By combining GLP-1 injections with advanced body composition analysis and tailored support, we ensure every patient receives a customized approach
Although long-chain omega-3 PUFA can reduce triglyceride concentrations, they have no effect on total cholesterol, LDL-cholesterol, or HDL-cholesterol in blood (103)
Nicolay JP, Gatz S, Lang F, Lang UE
doi: 46